NDC 0316-0123

Ala Quin

Hydrocortisone And Iodochlorhydroxyquin

Ala Quin is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Crown Laboratories. The primary component is Hydrocortisone; Clioquinol.

Product ID0316-0123_6371bf42-b0a0-66ec-e053-2a91aa0a893e
NDC0316-0123
Product TypeHuman Prescription Drug
Proprietary NameAla Quin
Generic NameHydrocortisone And Iodochlorhydroxyquin
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date1970-08-19
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameCrown Laboratories
Substance NameHYDROCORTISONE; CLIOQUINOL
Active Ingredient Strength5 mg/g; mg/g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0316-0123-01

1 TUBE in 1 CARTON (0316-0123-01) > 28.4 g in 1 TUBE
Marketing Start Date1970-08-19
Marketing End Date2021-11-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0316-0123-56 [00316012356]

Ala Quin CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1970-08-19
Marketing End Date2015-10-14

NDC 0316-0123-01 [00316012301]

Ala Quin CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date1970-08-19
Marketing End Date2021-11-30

NDC 0316-0123-80 [00316012380]

Ala Quin CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2015-11-12
Marketing End Date2020-12-31

Drug Details

Active Ingredients

IngredientStrength
HYDROCORTISONE5 mg/g

OpenFDA Data

SPL SET ID:d2ae30c6-ad64-47ed-b371-778eaebeeddf
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 206026
  • 309349
  • UPC Code
  • 0303160123016
  • 0303160123801
  • Pharmacological Class

    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]
    • Standardized Chemical Allergen [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Allergens [CS]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.